Sponsor

Bionor Immuno AS

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Bionor Immuno AS appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials6
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

6 shown
Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 ReservoirNCT02092116 · lead sponsor · 2014-03-01
COMPLETED
Re-boosting of HIV-1 Infected Subjects With Vacc-4xNCT01712256 · lead sponsor · 2012-12-01
COMPLETED
Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)NCT01704781 · lead sponsor · 2012-09-01
COMPLETED
Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ARTNCT01627678 · lead sponsor · 2012-09-01
COMPLETED
Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIVNCT00659789 · lead sponsor · 2008-08-01
COMPLETED
Intranasal Modified Vacc-4x Gag Peptides With Endocine as AdjuvantNCT01473810 · collaborator · 2011-11-01
COMPLETED

Sponsor roles

lead sponsor5
collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.